Related Experiment Video
Updated: May 25, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Transdiagnostic use of 3,4-methylenedioxymethamphetamine-assisted therapy to treat obsessive-compulsive disorder
Ziad Saade1, Alex S Keuroghlian1,2,3
1Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
Abstract:
This article explores the potential of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy to enhance exposure and response prevention in obsessive-compulsive disorder treatment. We discuss the mechanisms of MDMA, including fear extinction, psychological flexibility, and empathogenic effects that may improve adherence and efficacy, as well as highlighting important safety considerations for further research.
Insights
3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy may improve exposure and response prevention for obsessive-compulsive disorder. Its mechanisms, including fear extinction and enhanced empathy, show promise for treatment efficacy and adherence.
Area of Science:
- Psychopharmacology
- Clinical Psychology
- Neuroscience
Background:
- Obsessive-compulsive disorder (OCD) presents significant treatment challenges.
- Exposure and response prevention (ERP) is a primary therapy, but adherence and efficacy can be limited.
- Novel therapeutic adjuncts are needed to augment ERP effectiveness.
Purpose of the Study:
- To explore the potential of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy as an adjunct to ERP for OCD.
- To review the proposed mechanisms by which MDMA may enhance ERP.
- To identify safety considerations for future clinical research.
Main Methods:
- Literature review and theoretical analysis of MDMA's effects.
- Examination of MDMA's impact on fear extinction pathways.
- Discussion of MDMA's empathogenic and pro-social effects in therapeutic contexts.
Main Results:
- MDMA may facilitate fear extinction, a core process in ERP for OCD.
- Empathogenic effects of MDMA could improve patient-therapist rapport and treatment adherence.
- Psychological flexibility may be enhanced, aiding in overcoming OCD-related cognitive rigidity.
Conclusions:
- MDMA-assisted therapy shows potential as a novel treatment augmentation strategy for OCD.
- Further rigorous clinical trials are necessary to establish safety and efficacy.
- Understanding MDMA's neurobiological and psychological mechanisms is crucial for optimizing its therapeutic application.
Related Concept Videos
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Obsessive-Compulsive Disorder
Diagnostic and Statistical Manual of Mental Disorders (DSM)
Electroconvulsive Therapy
Operant Conditioning Intervention
In operant conditioning, behaviors that are...
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...

